Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Koppel currently holds 10,461 shares of Dicerna Pharmaceuticals Inc (DRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Koppel has been a net buyer of DRNA stock. They have purchased $273.4M and sold $164.3M worth of shares.
Adam Koppel's most recent insider trade was on Aug 1, 2024, when they sold 80,189 shares at $0.00 per share.
Adam Koppel serves as Executive at Dicerna Pharmaceuticals Inc (DRNA). They have executed 41 insider transactions totaling $437.7M over their tenure at the company.
Adam Koppel holds the position of Executive at Dicerna Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Adam Koppel has shown a buying trading pattern, with $273.4M in total purchases and $164.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Adam Koppel was on Oct 16, 2023, when they purchased $125.0M worth of CERE shares. This transaction involved 5,480,052 shares at $22.81 per share.
Adam Koppel currently owns 10,461 shares of Dicerna Pharmaceuticals Inc (DRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Koppel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Koppel has 41 Form 4 filings on record as an insider at Dicerna Pharmaceuticals Inc.
Set alerts for Adam Koppel and 40,000+ other insiders.